Wells Fargo’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,674
| Closed | -$299K | – | 8005 |
|
|
2022
Q1 | $299K | Sell |
10,674
-11,933
| -53% | -$327K | ﹤0.01% | 4752 |
|
|
2021
Q4 | $617K | Sell |
22,607
-2,773
| -11% | -$75.2K | ﹤0.01% | 4498 |
|
|
2021
Q3 | $690K | Sell |
25,380
-15,644
| -38% | -$387K | ﹤0.01% | 4475 |
|
|
2021
Q2 | $701K | Sell |
41,024
-23,482
| -36% | -$440K | ﹤0.01% | 4439 |
|
|
2021
Q1 | $1.35M | Sell |
64,506
-35,939
| -36% | -$829K | ﹤0.01% | 4032 |
|
|
2020
Q4 | $2.3M | Buy |
100,445
+2,690
| +3% | +$51.2K | ﹤0.01% | 3394 |
|
|
2020
Q3 | $1.59M | Sell |
97,755
-16,307
| -14% | -$295K | ﹤0.01% | 3496 |
|
|
2020
Q2 | $1.54M | Buy |
114,062
+43,104
| +61% | +$501K | ﹤0.01% | 3467 |
|
|
2020
Q1 | $842K | Buy |
70,958
+16,088
| +29% | +$357K | ﹤0.01% | 3652 |
|
|
2019
Q4 | $1.37M | Buy |
54,870
+1,035
| +2% | +$21K | ﹤0.01% | 3637 |
|
|
2019
Q3 | $916K | Sell |
53,835
-39,952
| -43% | -$727K | ﹤0.01% | 3914 |
|
|
2019
Q2 | $2.13M | Sell |
93,787
-16,443
| -15% | -$443K | ﹤0.01% | 3303 |
|
|
2019
Q1 | $3.54M | Sell |
110,230
-12,482
| -10% | -$386K | ﹤0.01% | 2871 |
|
|
2018
Q4 | $3.46M | Buy |
122,712
+14,563
| +13% | +$427K | ﹤0.01% | 2797 |
|
|
2018
Q3 | $3.11M | Sell |
108,149
-2,026
| -2% | -$60.9K | ﹤0.01% | 3039 |
|
|
2018
Q2 | $4.13M | Sell |
110,175
-7,075
| -6% | -$278K | ﹤0.01% | 2864 |
|
|
2018
Q1 | $4.61M | Buy |
117,250
+32,767
| +39% | +$1.2M | ﹤0.01% | 2697 |
|
|
2017
Q4 | $2.74M | Buy |
84,483
+33,007
| +64% | +$990K | ﹤0.01% | 3121 |
|
|
2017
Q3 | $1.6M | Buy |
51,476
+2,666
| +5% | +$78.9K | ﹤0.01% | 3470 |
|
|
2017
Q2 | $1.36M | Sell |
48,810
-23,967
| -33% | -$543K | ﹤0.01% | 3495 |
|
|
2017
Q1 | $1.25M | Sell |
72,777
-24,700
| -25% | -$346K | ﹤0.01% | 3576 |
|
|
2016
Q4 | $1.18M | Sell |
97,477
-6,432
| -6% | -$83.3K | ﹤0.01% | 3567 |
|
|
2016
Q3 | $1.65M | Buy |
103,909
+7,516
| +8% | +$113K | ﹤0.01% | 3114 |
|
|
2016
Q2 | $1.25M | Sell |
96,393
-2,330,210
| -96% | -$36.5M | ﹤0.01% | 3325 |
|
|
2016
Q1 | $46.1M | Buy |
2,426,603
+137,878
| +6% | +$2.5M | 0.02% | 799 |
|
|
2015
Q4 | $51.5M | Buy |
2,288,725
+607,788
| +36% | +$12M | 0.02% | 758 |
|
|
2015
Q3 | $39.3M | Buy |
1,680,937
+747,662
| +80% | +$20.6M | 0.02% | 877 |
|
|
2015
Q2 | $26.7M | Buy |
933,275
+132,207
| +17% | +$3.46M | 0.01% | 1168 |
|
|
2015
Q1 | $20.7M | Buy |
801,068
+229,690
| +40% | +$5.25M | 0.01% | 1318 |
|
|
2014
Q4 | $10.6M | Buy |
571,378
+189,599
| +50% | +$3.41M | ﹤0.01% | 1782 |
|
|
2014
Q3 | $5.92M | Buy |
+381,779
| New | +$5.75M | ﹤0.01% | 2175 |
|
Wells Fargo's XENT Position: Q2 2022 in Review
Wells Fargo sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 10,674 shares — an estimated $299K sold.
Wells Fargo first reported a position in XENT in Q3 2014 and held it in 31 quarters. The position peaked at $51.5M in Q4 2015. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Wells Fargo reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Wells Fargo sold 10,674 Intersect ENT, Inc shares in Q2 2022, an estimated $299K.
- Wells Fargo first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 31 quarters.
- Wells Fargo's Intersect ENT, Inc position peaked at $51.5M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Wells Fargo's 13F filing for Q2 2022, filed 12 Aug 2022.